CASTAGNA, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 15.435
AS - Asia 15.239
NA - Nord America 13.019
SA - Sud America 3.707
Continente sconosciuto - Info sul continente non disponibili 1.175
AF - Africa 333
OC - Oceania 24
Totale 48.932
Nazione #
US - Stati Uniti d'America 12.308
RU - Federazione Russa 8.874
SG - Singapore 5.284
CN - Cina 5.046
BR - Brasile 3.043
HK - Hong Kong 1.725
VN - Vietnam 1.509
SE - Svezia 1.445
IT - Italia 1.389
RO - Romania 778
FR - Francia 735
DE - Germania 725
BD - Bangladesh 414
GB - Regno Unito 404
CA - Canada 345
IN - India 290
AR - Argentina 267
FI - Finlandia 255
MX - Messico 178
AT - Austria 171
ID - Indonesia 151
PL - Polonia 137
IQ - Iraq 122
ZA - Sudafrica 119
NL - Olanda 116
EC - Ecuador 105
JP - Giappone 98
ES - Italia 97
TR - Turchia 96
CO - Colombia 84
IE - Irlanda 64
PK - Pakistan 61
VE - Venezuela 57
UA - Ucraina 55
LT - Lituania 53
PY - Paraguay 50
MA - Marocco 48
MY - Malesia 47
SA - Arabia Saudita 46
CL - Cile 45
PH - Filippine 39
UZ - Uzbekistan 39
EG - Egitto 37
JM - Giamaica 34
AE - Emirati Arabi Uniti 31
TN - Tunisia 29
NP - Nepal 28
IR - Iran 26
CR - Costa Rica 22
BE - Belgio 21
IL - Israele 21
KE - Kenya 21
PE - Perù 21
DZ - Algeria 20
HN - Honduras 20
UY - Uruguay 20
AU - Australia 19
DO - Repubblica Dominicana 19
GT - Guatemala 17
KR - Corea 17
TH - Thailandia 17
AZ - Azerbaigian 16
KZ - Kazakistan 16
MD - Moldavia 14
NI - Nicaragua 14
OM - Oman 14
AL - Albania 13
LB - Libano 13
CH - Svizzera 12
JO - Giordania 12
SY - Repubblica araba siriana 12
EU - Europa 11
BO - Bolivia 10
CI - Costa d'Avorio 10
TT - Trinidad e Tobago 10
BB - Barbados 9
CZ - Repubblica Ceca 9
PA - Panama 9
PR - Porto Rico 9
PT - Portogallo 9
SV - El Salvador 9
ET - Etiopia 8
NG - Nigeria 8
RS - Serbia 8
HR - Croazia 7
KW - Kuwait 7
LU - Lussemburgo 7
AM - Armenia 5
BH - Bahrain 5
GA - Gabon 5
GE - Georgia 5
NO - Norvegia 5
QA - Qatar 5
SI - Slovenia 5
SN - Senegal 5
BG - Bulgaria 4
BW - Botswana 4
BZ - Belize 4
DK - Danimarca 4
GY - Guiana 4
Totale 47.690
Città #
Singapore 2.452
Dallas 2.267
Moscow 1.931
Hong Kong 1.704
Ashburn 1.432
San Jose 1.405
Council Bluffs 848
Shanghai 822
Hefei 685
Lauterbourg 589
New York 546
Lawrence 542
Princeton 542
Beijing 539
Ho Chi Minh City 526
Shenzhen 447
Milan 405
Hanoi 335
Los Angeles 310
Santa Clara 280
São Paulo 280
Nuremberg 203
Munich 201
Helsinki 156
Orem 155
Boardman 127
Denver 117
Warsaw 114
Rome 111
Montreal 107
Rio de Janeiro 94
Atlanta 86
Tokyo 85
Brooklyn 84
Guangzhou 84
Chennai 83
Da Nang 83
London 83
Chicago 76
Washington 73
Johannesburg 72
Houston 71
Phoenix 71
Poplar 70
Haiphong 69
Toronto 67
Vienna 67
Frankfurt am Main 65
Mexico City 64
Seattle 61
Stockholm 61
Belo Horizonte 60
Curitiba 60
Amsterdam 59
Dublin 59
Turku 58
Manchester 57
Brasília 54
Baghdad 52
Buffalo 47
Campinas 46
Porto Alegre 43
Biên Hòa 42
Quito 40
Cesano Boscone 39
Falkenstein 39
Boston 38
Lappeenranta 38
Tashkent 38
Pune 37
Philadelphia 36
Ankara 34
Miami 34
Hangzhou 33
Mumbai 33
Bologna 32
Guayaquil 32
Hải Dương 32
Columbus 31
San Francisco 30
The Dalles 30
Tianjin 29
Naples 28
Salvador 28
St Petersburg 28
Turin 28
Las Vegas 27
Jakarta 26
Querétaro 26
Barnet 25
Brescia 25
Dhaka 25
Istanbul 25
New Delhi 25
Thái Bình 25
Buenos Aires 24
Gatchina 24
Goiânia 24
Guarulhos 24
Kuala Lumpur 24
Totale 23.500
Nome #
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients 1.366
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 471
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 270
Monkeypox in a patient with undifferentiated connective tissue disease 253
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment 252
Viral bloodstream detection in mpox patients: An observational multicentric study 236
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 212
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 197
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 184
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 180
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 175
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 156
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 156
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 154
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 153
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 153
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients 153
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 153
Biobanking for COVID-19 research 149
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 147
A follow-up study in asymptomatic HIV patients 147
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 146
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 145
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 138
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics 136
Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy 136
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 135
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 135
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure 133
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 133
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 130
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 127
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 125
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 125
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 124
Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy 123
HIV viral load monitoring during monkeypox virus infection among people with HIV 123
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 123
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 123
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 121
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients 120
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 119
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 119
A whole-genome association study of major determinants for host control of HIV-1 118
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 118
Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience 117
Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy) 117
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 117
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 117
Subclinical myocardial dysfunction in patients recovered from COVID-19 117
Achieving virological control in pan-resistant HIV-1 infection: A case series 115
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 115
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 115
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 115
Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report 114
Testosterone in males with COVID-19: A twelve-month cohort study 114
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 114
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 114
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 114
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients 113
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination 112
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort 112
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia 112
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 111
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 111
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 111
Risk of Cardiovascular Diseases or Mortality in People with Higher Values of HIV-1 DNA 110
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV 110
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV 110
Viral Hepatitis and Human Papillomavirus Vaccination during HIV Pre-Exposure Prophylaxis: Factors Associated with Missed Vaccination 109
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach 109
Severely low testosterone in males with COVID-19: a case-control study 109
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids 108
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 108
Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective 108
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial 108
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 108
High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy 107
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 107
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 107
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients 107
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 107
Beyond stigma: Monkeypox infection in a 27-year-old woman 106
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus 106
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study 105
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial 105
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient 105
Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor-Based Combination Antiretroviral Therapy: The D:A:D Study 105
Probable West Nile Virus hepatitis: Case report 104
Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach 104
Tick-borne encephalitis seroprevalence in northern Italy: a cross-sectional study on a randomly selected population 104
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 104
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 104
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 103
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 103
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 103
Effectiveness and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide therapy in an observational Italian cohort: The DIAMANTE study 103
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir 103
Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment 103
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 103
Totale 14.394
Categoria #
all - tutte 296.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 296.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022416 0 0 0 137 26 29 36 64 36 29 16 43
2022/20232.835 1.206 552 220 27 36 257 175 185 99 19 35 24
2023/20242.162 45 66 641 171 178 410 59 180 8 45 113 246
2024/20259.554 1.078 150 178 281 363 852 2.013 777 1.368 1.050 587 857
2025/202630.943 2.115 2.342 2.648 4.230 2.273 989 2.700 2.187 7.675 1.818 1.094 872
2026/20272.356 936 1.420 0 0 0 0 0 0 0 0 0 0
Totale 48.932